• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • First-ever CPPD classification criteria presented

    First-ever CPPD classification criteria presented

    December 2, 2022

    The proposed criteria, in development since 2019, will help clinicians more accurately diagnose and treat calcium pyrophosphate deposition disease and encourage renewed research into this disease, said Sara K. Tedeschi, MD, MPH, who was one of the co-leaders of the criteria project.

  • New ACR vaccination guideline in press

    New ACR vaccination guideline in press

    November 13, 2022

    With the recognition that rheumatic and musculoskeletal diseases (RMDs) and immunosuppression can affect the immunogenicity and safety of vaccines, the ACR has issued its own guideline for vaccination in patients with RMDs. Project leader Anne Bass, MD, and other panelists outlined the new recommendations at…

  • Plenary II details data on biosimilar switching, co-pays, and other new research

    Plenary II details data on biosimilar switching, co-pays, and other new research

    November 13, 2022

    The second of three plenary sessions addressed ground-breaking developments in rheumatic diseases, including Sjögren’s syndrome, systemic sclerosis, lupus, and osteoarthritis. Raisa Lomanto Silva, MD, discussed drug co-pay costs and adherence.

  • Rheumatologists can help young patients to preserve their reproductive health

    Rheumatologists can help young patients to preserve their reproductive health

    November 13, 2022

    Children with rheumatic disease often become adults with rheumatic disease. Cuoghi Edens, MD, FAAP, and Jacqueline Maher, MD, discussed how rheumatology providers can support reproductive health and protect fertility in adolescent patients.

  • Experts offer guidance on contraception safety, legal risks in reproductive health session

    Experts offer guidance on contraception safety, legal risks in reproductive health session

    November 13, 2022

    Panelists including Megan Clowse, MD, MPH, offered practical guidance and tools for discussing contraception and family planning with rheumatology patients. She encouraged honest, accurate conversation, as well as creating an environment of trust and safety.

  • Open communication facilitates dignity and respect in care of gender-diverse patients

    Open communication facilitates dignity and respect in care of gender-diverse patients

    November 13, 2022

    Many transgender and non-binary patients avoid seeking care because of the discrimination they have faced in the clinic. This lack of care can lead to chronic health issues, said Nathan Levitt, FNP-BC, MSN, RN, BSN, MA, in a session on strategies for improving the clinical…

  • Experts debate the role of DMARDs in subclinical RA

    Experts debate the role of DMARDs in subclinical RA

    November 13, 2022

    During this year’s Great Debate, experts including Janet Pope, MD, MPH, FRCPC, and Hani El-Gabalawy, MD, FRCPC, reviewed the data on subclinical disease and the risk of progression to rheumatoid arthritis, presenting arguments for and against starting a DMARD in this challenging clinical scenario.

  • Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era

    Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era

    November 13, 2022

    Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.

  • Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment

    Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment

    November 13, 2022

    Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.

  • Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block

    Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block

    November 13, 2022

    Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk.

Previous Page
1 2 3 4 5 … 10
Next Page

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy